Join us for a demo of the tool that can help your company be in compliance with the code of ethics. Powered by HealthStream, the AdvaMed Code of Ethics is a four-module course that guides learners through ethical challenges they may encounter in real-world interactions with Health Care Professionals (HCPs). Learn more about the role of compliance in medtech, including how to recognize unlawful inducements, how to evaluate consulting arrangements, communications, and technical support in clinical settings, and how to analyze applications of legitimate need, including grants, donations, promotional items, and gifts during this demo.

You will also receive a detailed overview of the Code of Ethics course design, structure, and measurable outcomes.

Please join us on February 20th, 2025 at 10 AM CT for this insightful webinar presentation.

Chandra N. Branham, JD, Sr. Director, Payment & Care Delivery, Health Policy, Johnson & Johnson

Chandra Branham, JD, joined Johnson & Johnson’s Global Government Affairs and Policy team in January 2023 as Senior Director, leading health policy development for the medtech sector. She had most recently served as Senior Vice President, Payment and Health Care Delivery Policy, at the Advanced Medical Technology Association (AdvaMed), since 2011, where she led AdvaMed’s policy work in a number of areas, including Medicare coverage and payment issues, diagnostic payment, and value of medical technology. Prior to joining AdvaMed, Ms. Branham was an associate at large D.C. law firm where she focused on healthcare regulatory and legislative issues involving Medicare coverage, coding, reimbursement and quality for providers and suppliers of Medicare items and services.

Ms. Branham previously was a senior legislative analyst at the Centers for Medicare & Medicaid Services (CMS) Office of Legislation; and early in her career, served as associate director of regulatory affairs at the National Association for Home Care. She has a Bachelor of Science degree from Drexel University and a JD from the George Mason University School of Law.

Megan Anderson Brooks, PhD, President, Innovation Policy Solutions LLC

Megan Anderson Brooks, President at Innovation Policy Solutions LLC, has expertise in science and health advocacy strategies in support of an innovative and robust biomedical research system. Megan focuses on science and regulatory policy related to basic and clinical scientific research, personalized medicine, federal oversight of diagnostics and biotech devices, and patient-specific issues related to access and patient-centered treatment development. On behalf of clients, she assists in the development and implementation of policy strategies; coordinates congressional briefings and public policy symposiums; organizes client advocacy days on Capitol Hill; facilitates report language requests, and engages in direct lobbying.

As a researcher in the field of neuroscience for over a decade, Megan brings first-hand experience and a deep scientific understanding to her work on behalf of clients. She conducted research on brain health and the neural mechanisms of learning and memory, and is best known for her work to understand the role of learning in the formation of new neurons in the adult brain.

Megan previously served as a Vice President for over four years at CRD Associates. She also worked for the Society for Neuroscience developing grassroots advocacy activities and on issues related to research replicability. During a fellowship placement at the New Jersey Department of Health, she assisted in the development of a successful CDC-awarded program that aimed to promote healthy behaviors, increase electronic health record adoption, and develop community-clinical linkages to prevent and control chronic disease in the State.

Amanda Cassidy, MPP, Senior Health Policy Advisor, Arnold & Porter

Amanda Cassidy is a Senior Health Policy Advisor at Arnold & Porter and focuses on healthcare regulatory issues involving coverage, coding and payment under Medicare. Former staff in the Center for Medicare and the Office of Legislation at the Centers for Medicare & Medicaid Services (CMS), she works with device and drug manufacturers on reimbursement strategy, including developing applications for code requests and for new technology payments. She has a Master’s in Public Policy from the College of William and Mary and lives in Richmond, VA.

Sara Davis, MPH, Senior Director, Global Operations and Market Access, Health Economics & Reimbursement, Abbott Medical Devices

Sara Davis joined Abbott Medical Devices in 2016, with responsibility for developing reimbursement strategy and policy for newly approved FDA products across 5 different cardiovascular and neuromodulation therapy areas. Her areas of responsibility have grown from Payer Relations to include Operations, Customer Education and Clinical Trial Reimbursement across North and South America. Attention has primarily focused on strategic planning, correct coding initiatives, education of regional & national payors, and implementation of programs to ensure procedure approval without payer coverage, while working with clinical affairs to develop publications that will push payer coverage.

Prior to joining Abbott, Sara Davis was the Senior Director of Payer Relations and Reimbursement at Torax Medical and Director of Payer Relations and Reimbursement at Hologic, Inc. In her twelve years with the 2 companies, she was responsible for staff management, strategic planning, managed care initiatives & marketing activities, as well as reimbursement analysis for prospective company/product acquisitions.

Mark D. Domyahn, MBA, Partner, JD Lymon Group

Mark has committed his 25+ year career entirely in the health care industry with the vast majority focused on medical technology, provider reimbursement and health economics. Prior to joining JD Lymon, Mark founded Pursuance Consulting, a reimbursement and health economics consulting practice. As a consultant with JD Lymon and Pursuance Consulting, Mark has developed reimbursement strategies and executed implementation plans for numerous products for medical device and pharmaceutical companies ranging in size from start-ups to Fortune 500 companies. Direct results of Mark’s efforts include establishing payment levels for technologies prior to FDA approval, securing multiple new technology payments from Medicare, creating new CPT and HCPCS codes and engaging CMS, physician societies and other interested stakeholders to support overall reimbursement for a variety of technologies.

Mark has also served in reimbursement related leadership positions at medical device companies, including Medtronic, St. Jude Medical, Restore Medical, CardioMEMS, and Zimmer. In those roles, he had success in formulating and executing reimbursement and health economic strategies for multiple therapy areas including heart failure, cardiology, neuromodulation, orthopedics, and sleep disorders. In these roles, Mark successfully integrated reimbursement and health economics into overall business strategies to accelerate market access and increase product adoption.

Deborah R. Godes, MBA, Vice President, McDermott+ Consulting

Deborah Godes is a Vice President at McDermott+Consulting, a consulting firm that serves health industry clients with market access and policy experience supported by data analytics capabilities. Deborah is a seasoned regulatory and reimbursement consultant, advising clients on reimbursement and policy strategy for diagnostics, medical devices, biologics, and health services with public and private payers, including CMS and managed care organizations. She focuses primarily on coding, coverage, payment and other reimbursement models for new and existing products and services. She has over twenty years of experience providing strategic, operational and policy consultative services to companies of all sizes from start-up organizations to Fortune 50 companies. Deborah offers clients the ability to analyze and manipulate reimbursement databases to buttress data-oriented policy positions.

Tom A. Gustafson, PhD, Senior Policy Advisor, Arnold & Porter

Thomas Gustafson, Ph.D., is Senior Policy Advisor at Arnold & Porter, where he concentrates on health care policy and reimbursement issues. Since joining Arnold & Porter in 2008, he has advised health-care providers, device and pharmaceutical manufacturers, and trade associations on a wide array of issues, including physician, outpatient hospital clinical laboratory, and end-stage renal disease reimbursement systems; accountable care organizations; and launch and reimbursement issues, inlcuding coverage, coding and payment, for devices, laboratory tests, and pharmaceuticals.

Dr. Gustafson spent 32 years at the Department of Health and Human Services, in the Office of the Assistant Secretary for Planning and Evaluation and in the Centers for Medicare & Medicaid Services, where he held several executive posts responsible for Medicare and Medicaid legislation, strategic planning, research and demonstrations, and development and implementation of regulations. From 2003 to 2007, Dr. Gustafson served as Deputy Director of the Center for Medicare Management (CMM), which coordinated the fee-for-service portion of the Medicare program and set payment rates for more than a million providers. He supervised coding and payment policies affecting approximately $300 billion in Medicare spending on hospitals, physicians, nursing facilities, home health agencies, and other providers. He led the development and introduction of the hospital outpatient prospective payment system and major improvements in Medicare’s other payment policies and systems. He oversaw a sweeping reform, intended to improve accountability and efficiency, of Medicare’s administrative structure for paying claims. In 2006-2007, he served as Acting Director of the CMM.

Jennifer Leib, ScM CGC, Founder, Innovation Policy Solutions LLC

Jennifer Leib, founder of Innovation Policy Solutions LLC, began her career as a board-certified genetic counselor conducting clinical research in the Neurogenetics Branch at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health before being selected for the prestigious National Human Genome Research Institute (NHGRI)/American Society of Human Genetics’ Genetics and Public Policy Fellowship in 2003. Jennifer worked directly in the office of then NHGRI Director Francis S. Collins, M.D., Ph.D., and also worked on the late Senator Edward M. Kennedy’s Health, Education, Labor and Pensions Committee staff for two years before transitioning to lobbying by directing the Washington, DC office of Affymetrix, a California-based biotechnology company.

Jennifer helps clients navigate the evolving regulatory and reimbursement landscape for targeted therapeutics, laboratory-based diagnostics, and mobile and digital health technologies. Jennifer also specializes in assisting young companies and associations with building a brand presence in Washington through relationship building with advocates and policymakers. Some of her key professional accomplishments include leading the advocacy effort in support of the plaintiffs in the Supreme Court’s unanimous decision in the Association for Molecular Pathology vs. Myriad Genetics Inc. that invalidated gene patents, serving on the Executive Committee of the Coalition for Genetic Fairness which successfully advocated for the enactment of the Genetic Information Nondiscrimination Act, and more recently, successfully securing national coverage for all types of SARS-Cov-2 diagnostics with varying regulatory approvals and statuses.

John S. McInnes, MD, JD, Counsel, Arnold & Porter

Dr. John McInnes, a board-certified ophthalmologist, is counsel at Arnold & Porter. He is fellowship trained in anterior segment surgery. He brings his medical experience to bear for life sciences clients navigating complex regulatory challenges. He rejoined Arnold & Porter in 2017, after almost eight years at CMS: as the Director of the Division of Outpatient Care in the Center for Medicare (OPPS/ASC), and as a Medical Officer at the Center for Medicare and Medicaid Innovation. He also served as Acting Director of the Division of Practitioner Services (PFS), the division responsible for the development of national Medicare payment policies for physician services.

In those roles at CMS, Dr. McInnes was often the principal liaison for life science companies and healthcare professional organizations, while reforming the OPPS and leading teams to develop new payment service delivery models that aim to achieve higher quality care for patients and lower costs through improvements in Medicare payment policy.

At Arnold & Porter Dr. McInnes works with both biopharmaceutical companies and medical device companies on a variety of complex reimbursement and compliance matters. He specializes in reimbursement strategy for new technologies.

Jason Bennett, Director of the Technology, Coding, and Pricing Group, Centers for Medicare & Medicaid Service

Jason Bennett is the Director of the Technology, Coding, and Pricing Group at the Centers for Medicare & Medicaid Services (CMS). This Group serves as a focal point for manufacturers to engage with Medicare fee-for-service on coding and payment for new products that Medicare beneficiaries and their clinicians may choose when making their health care decisions. Since joining CMS in 2017, Jason has served in leadership and senior advisor roles on Medicare policy and program issues. Prior to joining CMS, Jason served in a series of progressive management and analytical roles across the Department of Health and Human Services since 2005. His prior roles include serving in the Office of the Secretary, the Health Resources and Services Administration (HRSA), and as the first-ever chief of staff at the Administration for Community Living (ACL), working on aging and disability policies and programs. His broad range of operational and policy experience includes the response to the COVID-19 pandemic, 340B drug discount program, organ transplantation, workforce development and shortage issues, rural health, food and drug regulation, post-acute care and long-term services and supports, end-stage renal disease, the launch of the Medicare Part D program in 2005-2006, and budget formulation and execution.

Ben Finder, Vice President of Coverage Policy, American Hospital Association

Benjamin Finder, M.P.H., is Vice President of Coverage Policy at the American Hospital Association (AHA). He provides policy and data analysis to support the Association in its advocacy efforts and in the development of well-informed policy positions.

Prior to joining the AHA, he was a senior analyst at the Medicaid and CHIP Payment and Access Commission, a legislative advisory commission that provides policy analysis and makes recommendations to Congress. He has also served as an associate director at the District of Columbia’s Medicaid agency, the Department of Health Care Finance, and as a policy analyst at the Kaiser Family Foundation, where he performed data analysis of health expenditures, and trends in employer-sponsored health insurance.

Mr. Finder holds a Master of Public Health from The George Washington University, where he concentrated in health policy and health economics. He received his bachelor’s degree from Washington University in St. Louis.

Richard A. Frank, MD, PhD, Principal, Frank Healthcare Advisors, LLC

Zach Hochstetler, Vice President, Coding and Payment, American Medical Association

Zach Hochstetler is the director of CPT Editorial and Regulatory Affairs in the American Medical Association’s Health Solutions business unit. Zach’s work focuses on several key areas that include leading and setting strategic direction for the CPT Editorial Panel and directing the communication of health care policies, through identification and resolution of national payment and reporting problems. He is also the secretary of the CPT Editorial Panel, ensuring that the process remains open and transparent.

Ryan Howe, PhD, Director, CMS/Hospital & Ambulatory Policy Group

Ryan Howe is the Director of the Hospital and Ambulatory Policy Group in the CMS Center for Medicare. He has previously served in several leadership positions within the Center for Medicare and focused expertise on a wide range of payment issues, including for professional and other ambulatory services, hospital services, telehealth services and Part B drugs.

Julie Khani, Corporate Vice President, Government Affairs and Corporate Communications, Hologic

Julie Khani leads Hologic’s internal and external communications and government affairs strategies, enhancing and protecting the company’s reputation and brand with policymakers, the media, key stakeholders and the general public. She was president of the American Clinical Laboratory Association prior to joining Hologic in 2021. Previously, she served in senior roles at the National Association of Chain Drug Stores, Ford Motor Company and Planned Parenthood Pennsylvania Advocates. She holds a Bachelor of Arts from New York University and a Master of Public Administration from George Washington University.

Brian Lee, JD, MPH, Partner, Alston & Bird LLP

Brian Lee is a partner with Alston & Bird’s Health Care Group and focuses his practice on regulatory and legislative issues concerning federal reimbursement for and regulation of physicians, hospitals, post-acute care providers, insurers, and manufacturers. Brian assists clients in navigating Medicare coverage and reimbursement requirements and Medicare payment policies and provides counsel on the development and implementation of strategic initiatives in response to congressional and administrative coverage and reimbursement changes.

Brian currently serves as legislative and regulatory counsel for state and national health care trade associations, innovative technology manufacturers, and providers and suppliers participating in alternative payment models and delivery system reform initiatives.

Before joining Alston & Bird, Brian served as a consultant for a health care policy research and management consulting firm, where he advised government entities on congressional action and their impact on Medicare, counseled on Medicare reimbursement issues, and developed methods to assess, review, and evaluate alternative payment models, including changes that waive the Anti-Kickback Statute and Stark Law.

Chris Lyle, Partner, JD Lymon 

Josh Makower, MD, MBA, Director, Stanford Biodesign

Josh Makower is the Yock Family Professor of Medicine and Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign. Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created 10 companies over the past 20 years. Lastly, Josh is also a Senior Advisor to Patient Square Capital, and an Advisory Venture Partner with Sofinnova Partners. Josh currently serves on the boards of Elevage, Revelle Aesthetics, ExploraMed, Moximed, Willow, X9 and Coravin.

Josh holds over 300 patents and patent applications for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, plastic surgery, dermatology, aesthetics, obesity, orthopedics, women’s health, and urology. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a Bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering, a Fellow of The National Academy of Inventors and The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.

Andrey Ostrovsky, MD, Managing Partner, Social Innovation Ventures; Former US Medicaid Chief Medical Officer 

TJ Sutphin, Acting Pharmaceutical & Technology Ombudsman, Centers for Medicare & Medicaid Services

Anthony (TJ) Sutphin serves as the acting Medicare Pharmaceutical and Technology Ombudsman (PTO) within the Centers for Medicare & Medicaid Services (CMS) Offices of Hearings & Inquiries (OHI). In this capacity, he also serves as a new technology liaison working closely with colleagues in the Technology, Coding and Pricing Group and other CMS Groups to support engagement with medical device, pharmaceutical, and biotechnology manufacturers and other stakeholders. He has experience with and works to assist medical technology innovators with engaging CMS and addressing coding, payment, and coverage matters/concerns and inquiries. Prior to taking on this role, TJ worked as an Associate Ombudsman providing key support to the Medicare Beneficiary Ombudsman (MBO), Competitive Acquisition Ombudsman (CAO), and PTO in assisting Medicare beneficiaries and other stakeholders.

Tamara Syrek Jensen, JD, Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services

Tamara is the Director of the Coverage and Analysis Group in the Centers for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS). CAG is responsible for developing evidence based polices such as national coverage determinations (NCDs) and overseeing the local coverage determination process. Tamara leads the CMS collaboration with FDA, including the CMS-FDA parallel review program and the investigational device exemption (IDE) program. To assist in generating evidence for the Medicare population, Tamara is one of the principal authors in creating and implementing coverage with evidence development (CED), an initiative that allows for Medicare coverage while developing evidence through clinical studies, including registries. Tamara was recently awarded the 2022 CMS Executive of the Year.

Elizabeth Truong, MHS, Director of the Division of Policy Coordination and Implementation at the Centers for Medicare & Medicaid Services

Elizabeth Truong is the Director of the Division of Policy Coordination and Implementation at the Centers for Medicare & Medicaid Services (CMS). This Division is primarily responsible for providing oversight of Medicare’s local coverage determinations, implementation of national coverage determinations, and rulemaking for national coverage policies. Ms. Truong’s 20 years at CMS includes experience in developing Medicare payment policies to reimburse hospitals and clinicians (the Inpatient Prospective Payment System, the Long-Term Care Hospital Prospective Payment System, and the Physician Fee Schedule) as well as leading the development and implementation of innovative payment models that bundled hospital and physician reimbursement to better align payment incentives. She also served as the Director for the Budget and Audit Division at CMS’ Innovation Center.